Lipoprotein(a) levels in formerly small-for-gestational-age children

Area of Science:

• Cardiovascular Science
• Pediatric Endocrinology
• Metabolic Syndrome

Background:

• Lipoprotein(a) (Lp(a)) is an established inherited risk factor for coronary artery disease.
• While Lp(a) levels are studied in adolescents, data on children born small for gestational age (SGA) is limited.
• Intrauterine growth restriction may have long-term metabolic implications.

Purpose of the Study:

• To investigate the influence of intrauterine growth on serum Lp(a) concentrations in children.
• To compare Lp(a) levels in children born SGA versus those born adequate for gestational age (AGA).
• To explore the relationship between elevated Lp(a) and other metabolic parameters in SGA children.

Main Methods:

• Cross-sectional study comparing 50 SGA children and 21 AGA children.
• Measurement of serum Lp(a) and triglyceride levels.
• Statistical analysis to compare groups and assess correlations.

Main Results:

• SGA children exhibited significantly higher mean Lp(a) levels (22.3 +/- 22.1 mg/dl) compared to AGA children (10.9 +/- 7.6 mg/dl).
• A higher proportion of SGA children (14/50) had elevated Lp(a) (>30 mg/dl) versus AGA children (1/21).
• SGA children with elevated Lp(a) also showed higher triglyceride levels and an inverse correlation between Lp(a) and gestational age.

Conclusions:

• Intrauterine growth restriction is associated with elevated serum Lp(a) levels in childhood.
• Elevated Lp(a) in SGA children may be linked to other cardiovascular risk factors like higher triglycerides.
• These findings suggest that impaired fetal growth could influence Lp(a) levels and cardiovascular risk later in life.